AlzChem listed on the Frankfurt Stock Exchange
- AlzChem AG incorporated into the listed company AlzChem Group AG (formerly Softmatic AG)
- As of today, AlzChem shares can be traded on the Prime Standard of the Frankfurt Stock Exchange
- Half-year 2017 figures for sales and EBITDA above the previous year’s level
Trostberg, October 09, 2017 – AlzChem AG successfully took the step onto the Regulated Market (Prime Standard) of the Frankfurt Stock Exchange today by being incorporated into the listed Company AlzChem Group AG (formerly Softmatic; together with its subsidiaries hereinafter referred to as “AlzChem” or “AlzChem Group”). Starting today, a total of 101,763,355 shares of the vertically integrated specialty chemicals company with a leading market position in select niche markets are listed under the securities identification number A0AHT4. In addition to the capital increase by way of contribution in Kind of AlzChem AG to AlzChem Group AG, there was a cash capital increase, which resulted in gross proceeds of approximately EUR 2.6 million for the company. With the successful contribution of AlzChem AG, AlzChem Group AG is now the Group parent company of the AlzChem Group.
“We are convinced that making this move onto the capital market will be very helpful for the sustainably positive development of our company. We are thus opening up another option to finance our future growth. Furthermore, as a listed company, we will also benefit from the additional attention for our operating business and increase our attractiveness on the job market,” explained Ulli Seibel, CEO of AlzChem Group AG.
Expert on chemical products
As a vertically integrated chemical company with 1,468 employees (as of June 30, 2017), AlzChem manufactures and markets products of the calcium carbide/calcium cyanamide (NCN chain) for diversified markets. These are products with a typical nitrogen-carbon-nitrogen bond that are used in a variety of industries such as fine chemicals or agriculture. AlzChem has four production sites in Germany, a carbide plant in Sweden, a sales subsidiary in the US, and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.
The AlzChem Group's operating business can be divided into three segments along the entire valueadded chain. The Specialty Chemicals segment, which is the largest and accounts for 50% of the company’s sales, includes the manufacture and distribution of high-quality chemical products.The Basics & Intermediates business segment combines the production of chemical intermediates based on the starting materials calcium carbide and calcium cyanamide. These intermediate products are either sold directly to third parties or further processed into specialty chemical products. The third operating segment, Other & Holding, is responsible for all other activities. Essentially, these include services for the chemical parks that AlzChem operates (also for third parties) in Trostberg and Hart.
Half-year figures above the previous year’s level
AlzChem generated revenue of approximately EUR 182.8 million (previous year: EUR 173.5 million) in the first half of 2017. EBITDA grew disproportionately by 14.8% to EUR 27.9 million in the first six months of the year (previous year: EUR 24.3 million). “We developed well in operative terms in the first half of the year and are optimistic for the future. We will also be sharing our success with our employees by paying them a bonus for our stock exchange debut in the amount of one month’s salary,” said Chief Financial Officer Andreas Niedermaier. AlzChem Group AG will present its figures for the first nine months of the year on November 14, 2017.
Based in Trostberg, Bavaria, AlzChem Group AG is a vertically integrated manufacturer of various chemical products based on the NCN chain. These are products with typical nitrogen-carbon-Nitrogen bonding that are used in a wide variety of different industries. The company has a leading position in select niche markets, including the markets for feed additives and food supplements. The strategic focus of growth and the main focus of its extensive research and development are on the Business segment Specialty Chemicals. The company has 1,468 employees at four sites in Germany and three other sites abroad.